Position history for Alyeska Investment Group, L.P.'s holdings in VERTEX PHARMACEUTICALS INC
Alyeska Investment Group, L.P. holds 354,334 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $160.6M as of 2025-Q4. The position was increased (++32.6% shares). VRTX represents 0.5% of Alyeska Investment Group, L.P.'s portfolio.
Current Value
$160.6M
Current Shares
354,334
Total Value Change
+$159.1M
Total Shares Change
+350,981
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 354,334 |
+32.6% |
| $160.6M |
| 0.5% |
| $453.74 |
46 |
| 2025-Q3 | Increased | 267,169 | +311.0% | $104.6M | 0.3% | $395.31 | 58 |
| 2025-Q2 | Decreased | 65,000 | -85.0% | $28.9M | 0.1% | $441.30 | 0 |
| 2025-Q1 | Increased | 431,804 | +456.9% | $209.3M | 0.8% | $492.69 | 70 |
| 2024-Q4 | Increased | 77,535 | +2212.4% | $31.2M | 0.1% | $399.35 | 56 |
| 2024-Q3 | New | 3,353 | - | $1.6M | 0.0% | $462.88 | 35 |